I am a pharmacist in Vietnam and currently a Master of Philosophy student at School of Pharmacy, the University of Sydney, specializing in quality use of medicines, dementia, and digital health. My recent work focuses on the quality use of psychotropic medication in older adults and development of clinical prediction models to optimize psychotropic use.

Professor Shyamal Das is a Professor and the Associate Dean of Research at the School of Pharmacy, University of Otago, New Zealand. He completed his PhD in Pharmaceutics and a research fellowship at the Monash Institute of Pharmaceutical Sciences. Over the past 20 years, his primary research focus has been on powder characterization and innovative inhaler powder formulations for lung diseases. His recent projects include inhaled biologics, such as nanoparticulate miRNA delivery for COPD, and cannabidiol for asthma and COPD, as well as high-dose antibiotics for respiratory infections, including COVID-19. One of his inhaled antibiotic powders for tuberculosis has secured funding from the Health Research Council of New Zealand for a clinical trial. Professor Das has received several awards for research, teaching, and supervision. He is currently the President of the Controlled Release Society New Zealand Chapter and the Otago Medical School Research Society. He also serves on the editorial boards of two pharmaceutical science journals, Pharmaceutics and the International Journal of Pharmaceutics. Since 2015, he has been the only member from the Southern Hemisphere on the Drug Delivery to the Lung Scientific Committee.

Bushra is a 4th year pharmacy honours student at the University of Sydney. She is passionate about patient-centred and equitable healthcare and strives to improve culturally safe healthcare for First Nations peoples. She is currently undertaking an honours research project based in Dubbo to inform the culturally safe implementation of a transition of care program. She has worked in a small community pharmacy in Maroubra for almost 4 years and has found it extremely rewarding. Thank you to the Virtual Clinical Pharmacy Service team in the Western New South Wales Local Health District for their support and invaluable knowledge towards the project.

Dr Duaa Gaafar is a general paediatrician at the Royal Children's Hospital and an honorary research fellow at the Murdoch Children's Research Institute (MCRI). She specialises in paediatric clinical pharmacology and focuses on adverse drug reactions, drug allergies, and pharmacogenomics. Duaa is actively involved in research projects exploring drug-related adverse effects in children as part of her PhD, contributing to safer prescribing practices and advancing the field of paediatric pharmacology.

Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital, Brisbane, and a Research Conjoint with the School of Pharmacy, The University of QLD (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 8 HDR students who are conducting research related to medication safety, health informatics and advanced scope clinical pharmacy.

Dr Michael De Silva is a Senior Lecturer in the Department of Microbiology, Anatomy, Physiology and Pharmacology and Head of the Cerebrovascular Disease Division in the Centre for Cardiovascular Biology and Disease Research at La Trobe University. Michael earned his PhD from Monash University in 2011 and has completed a postdoctoral research position at the University of Iowa, USA. Michael’s current research interests include examining the effects of cardiovascular diseases (such as stroke and hypertension) on the regulation of cerebral microvascular function and cognitive function. He has been as ASCEPT member since 2008 and was co-chair of the Cardiovascular SIG (2019-2020).